(Adnkronos) - "Potrebbe essere rivista la possibilità di accesso ai farmaci e permettere che anche il medico di medicina generale possa effettuare un triage efficace”, per le malattie della pelle, “trattando a livello territoriale le patologie più agevolmente trattabili e inviare all'istituzione il paziente che necessita di cure più complesse”. Così, Luca Bianchi, professore di Dermatologia e direttore Unità operativa di Dermatologia policlinico Tor Vergata di Roma, partecipando all’evento ‘Equity Group’ sulle malattie croniche.
Category
🗞
NewsTranscript
00:00Probably it could be reviewed, first of all, the possibility of access to drugs that now occupy the forefront in the guidelines of therapy and through the formulation of biosimilars, which are economically extremely advantageous drugs,
00:25probably there could be a more shared use of these drugs and, fundamentally, the possibility of creating dedicated accesses and ensuring that even the doctor in general medicine, of course the specialist because he has his competence, can carry out such an effective triage,
00:48that is, to be able to treat at the territorial level those that are the most easily treatable pathologies and send to the institution the patient who needs the most complex cures.
01:01This, however, should not mean doctors of category A or doctors of category B and this could be overcome if there were shared accounts that allow access to the clinical and health information of the various patients.
01:19Another possibility could be to accelerate the diagnosis period through telemedicine.
01:27Teledermatology has been at the forefront, indeed my institution, my clinic, has been among the first to be interested in this modality, but for us it is a very delicate element because telemedicine would not just mean a sharing of radiographic imaging, resonance or laboratory tests,
01:49but we need to see the patient often, or at least episodically, in person because for us the material aspect of the assessment of clinical injury is fundamental.
02:06Now we are doing a better classification of the chronic characteristics of inflammatory disease, certainly psoriasis, but for example psoriasis, despite the spread of the disease, actually has an exemption only for some very rare forms of the disease, not in the most classic form, even if very serious.
02:29This is something that obviously greatly damages the patient, who may have to take advantage of exemptions due to other comorbidities that are often present in the patient with serious psoriasis.
02:43There are other diseases, such as atopic dermatitis, vitiligo, which are not surface diseases, but they are visible, so you can imagine how the patient follows day by day the evolution of his disease, the response to therapies, but how these affect not only from a psychological point of view on the quality of life of the patient,
03:09but it is now known that they share common inflammatory processes with other systemic diseases with a strong social impact, diabetes, hypertension, dysmetabolic syndromes and so on.